Clinical characteristics and outcomes of PCR-confirmed legionnaires’ disease identified by metagenomic sequencing in patients with hematological diseases
Frontiers in Cellular and Infection Microbiology · 20.11.2026 · 16
DOI: 10.3389/fcimb.2026.1826231 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 20.11.2026. Verfasst von Chunhui Xu und 13 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Legionnaires’ disease (LD) is a severe form of pneumonia associated with high mortality in hematological patients, often due to delayed diagnosis. This study aimed to investigate clinical features, clinical severity, co-infections, molecular testing findings, and factors associated with 28-day mortality.
Methods
We retrospectively included hematological patients with pneumonia in whom Legionella pneumophila was detected by metagenomic next-generation sequencing (mNGS) and confirmed by PCR. Clinical, imaging, laboratory, treatment, and outcome data were collected.
Results
Among the 54 patients, 51.9% had severe LD and the overall 28-day mortality was 35.2%. In those with severe LD, the 28-day mortality was 67.9% (19/28). The main manifestations were fever (100%) and respiratory symptoms (cough 92.6%, expectoration 79.6%, dyspnea 64.8%). Imaging showed mass-like consolidation as the predominant pattern (61.1%), resembling invasive fungal pneumonia. Co-infections were identified in 61.1% of patients. In exploratory multivariable Cox analysis, elevated C-reactive protein (CRP) (HR = 1.106 per 10-mg/L increase, 95% CI, 1.035–1.186, P = 0.003) and higher blood-mNGS species-level stringently mapped read number (SMRN) (HR = 2.645 per tenfold increase, 95% CI, 1.523–5.008, P < 0.001) were associated with increased 28-day mortality. Before mNGS detection of L. pneumophila , only seven patients (13.0%) received empiric anti- Legionella therapy.
Conclusions
LD is a serious and potentially underrecognized infection in patients with hematological diseases. mNGS may facilitate the recognition of L. pneumophila infection when Legionella is not initially suspected. The observed associations of host inflammatory responses and microbial sequencing signals with mortality may help identify patients at higher risk of poor outcomes, although their clinical utility requires further validation.
Zitieren
APA
Xu, C., Zhang, L., Chen, S., Liu, T., Zhu, G., Pan, L., Wei, H., An, G., Shi, J., Song, Y., Yang, W., Jiang, E., Yi, H., & Feng, S. (2026). Clinical characteristics and outcomes of PCR-confirmed legionnaires’ disease identified by metagenomic sequencing in patients with hematological diseases. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1826231
Vancouver
Xu C, Zhang L, Chen S, Liu T, Zhu G, Pan L, et al. Clinical characteristics and outcomes of PCR-confirmed legionnaires’ disease identified by metagenomic sequencing in patients with hematological diseases. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1826231
BibTeX
@article{Xu2026,
author = {Xu, Chunhui and Zhang, Lining and Chen, Shulian and Liu, Teng and Zhu, Guoqing and Pan, Ling and Wei, Hui and An, Gang and Shi, Jun and Song, Yijun and Yang, Wenyu and Jiang, Erlie and Yi, Huiming and Feng, Sizhou},
title = {Clinical characteristics and outcomes of PCR-confirmed legionnaires’ disease identified by metagenomic sequencing in patients with hematological diseases},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1826231}
}
EUVIMED